shortagewatch

Home / Companies / Aspen

Company family · HQ ZA

Aspen: medicine shortages

APN · JSE

As of 2 Nov 2026, 41 Aspen products have a reported shortage across 10 countries, covering 13 medicines.

Products short41rank #45 of 464
Medicines13active ingredients
Countries10/16
New in 90 days9+9 vs market pace
Typical duration12 monthsmedian so far
Manufacturing55%demand-driven 3%

Where

Canada7Germany10Italy8Ireland2Austria3Belgium2Switzerland1Czechia4Norway2Sweden2

Which therapeutic classes

Musculoskeletal system14Nervous system13Blood7Genito-urinary system and sex hormones3Systemic hormones3Cardiovascular system1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
AspenAspen: Manufacturing problem 21 (54%)54%Aspen: Increased demand 1 (3%)Aspen: Distribution or logistics 3 (8%)8%Aspen: Commercial decision or withdrawal 2 (5%)5%Aspen: Other 9 (23%)23%Aspen: Not stated 3 (8%)8%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

Open shortages over time

1920202131 Oct2026-10-31: 201 Nov2026-11-01: 202 Nov2026-11-02: 20

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

01235Dec: 2Jan ’25: 0Feb: 1FebMar: 0Apr: 0May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 3NovDec: 1Jan ’26: 0Feb: 1FebMar: 1Apr: 3May: 3MayJun: 0Jul: 0Aug: 3AugSep: 2Oct: 4Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0122537502017: 1820172018: 2320182019: 720192020: 1820202021: 2220212022: 3420222023: 3620232024: 4220242025: 132025

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Aspen41

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Aspen: 41 / 13Aspen

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Nadroparin729 Oct 2020Distribution or logistics2/16
Cisatracurium617 Jun 2024Manufacturing problem6/16
Mivacurium Chloride51 Nov 2025Manufacturing problem4/16
Propofol527 Dec 2024Manufacturing problem6/16
Atracurium317 Dec 2025Quality problem or recall5/16
Desogestrel and Ethinylestradiol331 Mar 2023Other1/16
Bupivacaine211 Sep 2026Manufacturing problem8/16
Levothyroxine Sodium21 Nov 2024Manufacturing problem6/16
Lidocaine223 Apr 2026Manufacturing problem9/16
Dexamethasone123 Oct 2026Manufacturing problem10/16
Labetalol115 Jul 2022Commercial decision or withdrawal2/16
Prilocaine113 Oct 2026Other1/16
Remifentanil11 Mar 2026Commercial decision or withdrawal5/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.